neXus
2021-06-08
global aging population is increasing. solution will be needed to take care of them. affordable solution will be disruptive
@话题虎:
老年痴呆概念股起飞啦!你看好吗?
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":117127069,"tweetId":"117127069","gmtCreate":1623124329051,"gmtModify":1631893470263,"author":{"id":3571919417372929,"idStr":"3571919417372929","authorId":3571919417372929,"authorIdStr":"3571919417372929","name":"neXus","avatar":"https://static.tigerbbs.com/3f5527e97f3d63e3fa0d4f05b7f5230c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\nglobal aging population is increasing. solution will be needed to take care of them. affordable solution will be disruptive</body></html>","htmlText":"<html><head></head><body>\nglobal aging population is increasing. solution will be needed to take care of them. affordable solution will be disruptive</body></html>","text":"global aging population is increasing. solution will be needed to take care of them. affordable solution will be disruptive","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/117127069","repostId":117128195,"repostType":1,"repost":{"magic":2,"id":117128195,"tweetId":"117128195","gmtCreate":1623124022713,"gmtModify":1623209622995,"author":{"id":3502767768442965,"idStr":"3502767768442965","authorId":3502767768442965,"authorIdStr":"3502767768442965","name":"话题虎","avatar":"https://static.tigerbbs.com/d418c2def5dc1d094b03270b450f71ce","vip":4,"userType":4,"introduction":"热点追踪小能手,为大家捕捉每日最热市场话题","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":36362,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/5e8de7cc84d3d4b2514a72e4863ebfe7","width":"400","height":"257"},{"img":"https://static.tigerbbs.com/a27c61de2bfbc3d5974a2de163edf9ff","width":"840","height":"470"},{"img":"https://static.tigerbbs.com/e4fd1aa1ac3f59d90eeb5c35b5e3a73b","width":"674","height":"459"}],"coverImages":[{"img":"https://static.tigerbbs.com/5e8de7cc84d3d4b2514a72e4863ebfe7","width":"400","height":"257"},{"img":"https://static.tigerbbs.com/a27c61de2bfbc3d5974a2de163edf9ff","width":"840","height":"470"},{"img":"https://static.tigerbbs.com/e4fd1aa1ac3f59d90eeb5c35b5e3a73b","width":"674","height":"459"}],"title":"老年痴呆概念股起飞啦!你看好吗?","extraTitle":"","html":"<html><head></head><body><p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/5e8de7cc84d3d4b2514a72e4863ebfe7\" tg-width=\"400\" tg-height=\"257\">今天,美国食品和药物管理局FDA批准了<a target=\"_blank\" href=\"https://laohu8.com/S/BIIB\">$百健(BIIB)$</a> 的阿尔茨海默氏症(老年痴呆症)治疗药物Aduhelm,公司股价盘中一度大涨60%:<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/a27c61de2bfbc3d5974a2de163edf9ff\" tg-width=\"840\" tg-height=\"470\">据阿尔茨海默氏症协会估计,有超过600万美国人患有此病,因为无法得到有效的治疗,到2050年,这一数字预计将上升到近1300万。据有关专家分析,我国老年痴呆症患者比美国还要严重,数量可能是美国的2倍。<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/e4fd1aa1ac3f59d90eeb5c35b5e3a73b\" tg-width=\"674\" tg-height=\"459\">得了老年痴呆症的人,会逐渐丧失记忆力,直到丧失动机力、无法自理,最终丧失身体机能,导致死亡。这种破坏记忆的疾病是美国第六大死亡原因,治疗选择非常有限,诊断后的平均余命仅为为三到九年。</p> <p>百健的药物获批是革命性的,因为这是美国批准的第一种减缓老年痴呆症认知能力下降的药物,<b>也是近20年来第一种治疗该疾病的新药,</b>对于老年痴呆症患者来说就是救命神药。</p> <p>除了百健外,其他阿尔茨海默病领域的公司也在争取获得批准:</p> <ul> \n <li><a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> 一度大涨17%;<a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a>一度大涨12%。</li> \n</ul> <p>更多相关阅读请看:<a href=\"https://laohu8.com/TW/117902499\" target=\"_blank\">老年痴呆症有救了 !20年来第一次,FDA批准百健新药</a></p> <p>……</p> <p>最后,大家聊一聊:</p> <ul> \n <li><span style=\"color:rgba(248,9,9,1);\"><b>你是否看好老年痴呆概念股?</b></span></li> \n</ul> <p>精彩留言用户可获得888社区积分噢!</p></body></html>","htmlText":"<html><head></head><body><p><img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/5e8de7cc84d3d4b2514a72e4863ebfe7\" tg-width=\"400\" tg-height=\"257\">今天,美国食品和药物管理局FDA批准了<a target=\"_blank\" href=\"https://laohu8.com/S/BIIB\">$百健(BIIB)$</a> 的阿尔茨海默氏症(老年痴呆症)治疗药物Aduhelm,公司股价盘中一度大涨60%:<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/a27c61de2bfbc3d5974a2de163edf9ff\" tg-width=\"840\" tg-height=\"470\">据阿尔茨海默氏症协会估计,有超过600万美国人患有此病,因为无法得到有效的治疗,到2050年,这一数字预计将上升到近1300万。据有关专家分析,我国老年痴呆症患者比美国还要严重,数量可能是美国的2倍。<img referrerpolicy=\"no-referrer\" src=\"https://static.tigerbbs.com/e4fd1aa1ac3f59d90eeb5c35b5e3a73b\" tg-width=\"674\" tg-height=\"459\">得了老年痴呆症的人,会逐渐丧失记忆力,直到丧失动机力、无法自理,最终丧失身体机能,导致死亡。这种破坏记忆的疾病是美国第六大死亡原因,治疗选择非常有限,诊断后的平均余命仅为为三到九年。</p> <p>百健的药物获批是革命性的,因为这是美国批准的第一种减缓老年痴呆症认知能力下降的药物,<b>也是近20年来第一种治疗该疾病的新药,</b>对于老年痴呆症患者来说就是救命神药。</p> <p>除了百健外,其他阿尔茨海默病领域的公司也在争取获得批准:</p> <ul> \n <li><a target=\"_blank\" href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a> 一度大涨17%;<a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a>一度大涨12%。</li> \n</ul> <p>更多相关阅读请看:<a href=\"https://laohu8.com/TW/117902499\" target=\"_blank\">老年痴呆症有救了 !20年来第一次,FDA批准百健新药</a></p> <p>……</p> <p>最后,大家聊一聊:</p> <ul> \n <li><span style=\"color:rgba(248,9,9,1);\"><b>你是否看好老年痴呆概念股?</b></span></li> \n</ul> <p>精彩留言用户可获得888社区积分噢!</p></body></html>","text":"今天,美国食品和药物管理局FDA批准了$百健(BIIB)$ 的阿尔茨海默氏症(老年痴呆症)治疗药物Aduhelm,公司股价盘中一度大涨60%:据阿尔茨海默氏症协会估计,有超过600万美国人患有此病,因为无法得到有效的治疗,到2050年,这一数字预计将上升到近1300万。据有关专家分析,我国老年痴呆症患者比美国还要严重,数量可能是美国的2倍。得了老年痴呆症的人,会逐渐丧失记忆力,直到丧失动机力、无法自理,最终丧失身体机能,导致死亡。这种破坏记忆的疾病是美国第六大死亡原因,治疗选择非常有限,诊断后的平均余命仅为为三到九年。 百健的药物获批是革命性的,因为这是美国批准的第一种减缓老年痴呆症认知能力下降的药物,也是近20年来第一种治疗该疾病的新药,对于老年痴呆症患者来说就是救命神药。 除了百健外,其他阿尔茨海默病领域的公司也在争取获得批准: $Cassava Sciences Inc(SAVA)$ 一度大涨17%;$礼来(LLY)$一度大涨12%。 更多相关阅读请看:老年痴呆症有救了 !20年来第一次,FDA批准百健新药 …… 最后,大家聊一聊: 你是否看好老年痴呆概念股? 精彩留言用户可获得888社区积分噢!","highlighted":2,"essential":2,"paper":2,"link":"https://laohu8.com/post/117128195","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["BIIB","LLY","SAVA"],"verified":2,"subType":2,"readableState":1,"subTypeObject":{"tweetId":117128195,"totalAmount":888,"balance":0,"end":true,"deadline":1623484022713,"description":"528虎币已分给6位参与者,剩余360虎币已退还至发起者","remainingNumber":94},"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":871,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":390,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":105,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/117127069"}
精彩评论